Comment
doi: 10.1056/NEJMc2025138.
Reconsidering the Trade-offs of Prostate Cancer Screening. Reply
Affiliations
- PMID: 32966736
- DOI: 10.1056/NEJMc2025138
Item in Clipboard
Comment
Reconsidering the Trade-offs of Prostate Cancer Screening. Reply
N Engl J Med.
.
No abstract available
Comment on
-
Reconsidering the Trade-offs of Prostate Cancer Screening.N Engl J Med. 2020 Sep 24;383(13):1289-1290. doi: 10.1056/NEJMc2025138. N Engl J Med. 2020. PMID: 32966735 No abstract available.
Similar articles
-
Reconsidering the Trade-offs of Prostate Cancer Screening.N Engl J Med. 2020 Sep 24;383(13):1289-1290. doi: 10.1056/NEJMc2025138. N Engl J Med. 2020. PMID: 32966735 No abstract available.
-
Reconsidering the Trade-offs of Prostate Cancer Screening.N Engl J Med. 2020 Jun 18;382(25):2465-2468. doi: 10.1056/NEJMsb2000250. N Engl J Med. 2020. PMID: 32558473 Free PMC article. No abstract available.
-
Men's preferences and trade-offs for prostate cancer screening: a discrete choice experiment.Health Expect. 2015 Dec;18(6):3123-35. doi: 10.1111/hex.12301. Epub 2014 Nov 10. Health Expect. 2015. PMID: 25382490 Free PMC article.
-
[Analysis of recommendations against prostate cancer screening with prostate specific antigen].Med Clin (Barc). 2016 Oct 21;147(8):361-365. doi: 10.1016/j.medcli.2016.03.002. Epub 2016 Apr 13. Med Clin (Barc). 2016. PMID: 27085747 Review. Spanish. No abstract available.
-
Prostate cancer screening.Investig Clin Urol. 2017 Jul;58(4):217-219. doi: 10.4111/icu.2017.58.4.217. Epub 2017 Jun 20. Investig Clin Urol. 2017. PMID: 28681029 Free PMC article. Review. No abstract available.
Cited by
-
Prostate cancer.Nat Rev Dis Primers. 2021 Feb 4;7(1):9. doi: 10.1038/s41572-020-00243-0. Nat Rev Dis Primers. 2021. PMID: 33542230 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
